Single-cell proteomics: potential implications for cancer diagnostics

Expert Review of Molecular Diagnostics
Bjørn T GjertsenJörn Skavland

Abstract

Single-cell proteomics in cancer is evolving and promises to provide more accurate diagnoses based on detailed molecular features of cells within tumors. This review focuses on technologies that allow for collection of complex data from single cells, but also highlights methods that are adaptable to routine cancer diagnostics. Current diagnostics rely on histopathological analysis, complemented by mutational detection and clinical imaging. Though crucial, the information gained is often not directly transferable to defined therapeutic strategies, and predicting therapy response in a patient is difficult. In cancer, cellular states revealed through perturbed intracellular signaling pathways can identify functional mutations recurrent in cancer subsets. Single-cell proteomics remains to be validated in clinical trials where serial samples before and during treatment can reveal excessive clonal evolution and therapy failure; its use in clinical trials is anticipated to ignite a diagnostic revolution that will better align diagnostics with the current biological understanding of cancer.

References

Jan 1, 1996·Biotechnology & Genetic Engineering Reviews·M R WilkinsK L Williams
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·H T ZhangJ Eberwine
Mar 5, 2002·Microbiology and Molecular Biology Reviews : MMBR·Paul R Graves, Timothy A J Haystead
Jun 5, 1962·Annals of the New York Academy of Sciences·B CHANCE
Sep 25, 2003·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Peter O Krutzik, Garry P Nolan
Mar 3, 2004·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Zbigniew DarzynkiewiczJames W Jacobberger
Apr 4, 2006·Nature Reviews. Drug Discovery·Stephen F Kingsmore
Apr 4, 2008·Electrophoresis·Hui YanHongkai Wu
May 22, 2009·Journal of Proteomics·Carl A K Borrebaeck, Christer Wingren
Jul 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hakho LeeRalph Weissleder
Jul 19, 2008·Annual Review of Analytical Chemistry·Daniella CohenNorman J Dovichi
Aug 25, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bob LöwenbergFaith Davies
Oct 4, 2011·Nature Biotechnology·Peng QiuSylvia K Plevritis
Oct 18, 2011·Expert Review of Proteomics·Kristin J BoggioJeffrey N Agar
Dec 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexander E PerlMartin Carroll
Dec 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qihui ShiJames R Heath
Mar 24, 2012·Science Translational Medicine·Ravi IyengarJames M Gallo
Apr 14, 2012·Journal of Proteomics·Eric J LanniJonathan V Sweedler
Jul 12, 2012·Nature Biotechnology·Sean C Bendall, Garry P Nolan
Jul 24, 2012·Cell·John S WelchRichard K Wilson
Oct 12, 2012·Virchows Archiv : an International Journal of Pathology·Jorunn LitlekalsoyOle Didrik Laerum
Jan 19, 2013·Leukemia·S MustjokiUNKNOWN Nordic CML Study Group (NCMLSG)
Mar 21, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Rachel FinckSean C Bendall
Apr 9, 2013·Cancer Immunology, Immunotherapy : CII·Scott D TannerThaddeus C George
Apr 18, 2013·Analytical Chemistry·Michelle L KovarikNancy L Allbritton

❮ Previous
Next ❯

Citations

Oct 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·André SulenBjørn T Gjertsen
Oct 21, 2016·Cell Biology and Toxicology·Michael P ChuLinda M Pilarski
Mar 31, 2017·Cell Communication and Signaling : CCS·Wolfgang GruberChristian G Huber
Jun 22, 2017·Trends in Biotechnology·Ouriel CaenValerie Taly
Aug 5, 2017·Frontiers in Microbiology·Yuting GuoSusann Müller
Aug 12, 2017·Biomicrofluidics·A A KimA Jesorka
Jan 28, 2021·Critical Reviews in Analytical Chemistry·Negin Fasih RamandiHassan Y Aboul-Enein
May 25, 2021·Mass Spectrometry Reviews·Rui HuMaili Liu
Mar 20, 2018·Analytical Chemistry·Zi-Yi LiQun Fang
Sep 28, 2021·Proteomics·Michal AlexovičRémi Longuespée

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

The Cancer Journal From Scientific American
E WoodhouseL A Liotta
Trends in Molecular Medicine
Randy Todd, David H Margolin
Advances in Cancer Research
Christopher Sears, Scott A Armstrong
Nature Methods
Kristin Hope, Mickie Bhatia
© 2022 Meta ULC. All rights reserved